Neumora Therapeutics operates as a clinical-stage biotechnology company.
Neumora Therapeutics has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Neumora Therapeutics's investors include ARCH Venture Partners, Catalio Capital Management, Polaris Partners, Premier Partners, Amgen.
Neumora Therapeutics is headquartered in Watertown, United States.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Neumora Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neumora Therapeutics — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/neumora-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Neumora Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neumora-therapeutics
{{cite web |title=Neumora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neumora-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated